Video-logs for HIV Prevention
(PrEP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to encourage Black women in Houston to use PrEP, a medication that helps prevent HIV, by sharing health-focused video-logs (vlogs). It also seeks to motivate healthcare providers to prescribe or recommend PrEP to Black women. Participants will either watch the video series or receive standard care. Black women who have been sexually active with a man in the past six months and have internet or phone access might be a good fit. Healthcare providers in the Houston area who treat Black women and can prescribe PrEP are also invited to participate. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants a chance to contribute to groundbreaking HIV prevention strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on increasing willingness to start PrEP among participants.
What prior data suggests that this video-log series is safe for participants?
Research has shown that video-log series have been used in other health education settings, but specific safety data for this method in HIV prevention trials is lacking. As an early phase trial, the main goal is to assess the approach's safety. These trials are typically small and closely monitored to identify any potential issues.
Video-log interventions are generally considered low-risk because they involve watching videos, a passive activity. Without medications or physical procedures, there are usually fewer safety concerns compared to trials involving new drugs. Prospective participants can expect to primarily engage with educational content.12345Why are researchers excited about this trial?
Researchers are excited about using video-logs (vlogs) for HIV prevention because this approach is innovative and engaging. Unlike traditional methods like medication or face-to-face counseling, vlogs offer an accessible and relatable way to deliver health information directly to individuals, potentially increasing awareness and understanding. This format leverages the power of visual storytelling to reach a broader audience, especially among younger, tech-savvy populations, making it a promising tool in the fight against HIV.
What evidence suggests that this video-log series is effective for increasing PrEP initiation among Black Women?
Research has shown that video blogs (vlogs) can effectively teach people about preventing HIV and encourage behavior changes. In this trial, participants in the intervention arm will watch a health-informed vlog series. Studies have found that vlogs can help viewers learn about HIV prevention methods like PrEP (pre-exposure prophylaxis). For instance, one study discovered that vlogs shared on social media spread accurate information about preventing HIV. Another study found that a web drama series successfully encouraged people to get tested for HIV and adopt prevention behaviors. These findings suggest that vlogs could be a useful tool to encourage Black women and healthcare providers to consider and promote PrEP.12467
Who Is on the Research Team?
Mandy Hill, DrPH,MPH,HIVPCP
Principal Investigator
University of Texas Medical Branch, Galveston
Are You a Good Fit for This Trial?
This trial is for cisgender Black women in Houston/Harris County interested in HIV prevention, and healthcare providers willing to prescribe/refer PrEP. Specific eligibility criteria are not detailed here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants will watch a health-informed video-log series and complete a second survey (post-test)
Follow-up
Participants are monitored for willingness to access/use PrEP and adherence to PrEP regimen
What Are the Treatments Tested in This Trial?
Interventions
- Video-log (vlog) series
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator